HopeStage
Back to all studies
WithdrawnNCT02811133

Inositol for Comorbid Anxiety in Children and Adolescents With Bipolarity

Medication studyAges 8–17United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 8 years to 17 years.

Listed locations
PittsburghSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: August 2023
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Ronald M. Glick, MD
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 8 Years to 17 Years
Official registry ID
NCT02811133
Official title
Show the full official title

Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder

Recruitment & locations

Withdrawn

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ronald M. Glick, MD.

Does this study involve medication?

Yes. The study involves medication, including Inositol.

Who can participate?

Listed age limits: 8 years to 17 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies